| Primary |
| Product Used For Unknown Indication |
19.6% |
| Acute Lymphocytic Leukaemia |
12.4% |
| Addison's Disease |
7.3% |
| Adrenal Insufficiency |
6.9% |
| Drug Use For Unknown Indication |
5.4% |
| Dermatitis Atopic |
4.8% |
| Adrenogenital Syndrome |
4.2% |
| B Precursor Type Acute Leukaemia |
4.2% |
| Colitis Ulcerative |
3.9% |
| Asthma |
3.6% |
| Eczema |
3.6% |
| Pain |
3.6% |
| Hypopituitarism |
3.3% |
| Non-hodgkin's Lymphoma |
3.0% |
| Chemotherapy |
2.4% |
| Immunosuppression |
2.4% |
| Lymphoblastic Lymphoma |
2.4% |
| Lymphocytic Leukaemia |
2.4% |
| Adrenal Disorder |
2.1% |
| Bone Marrow Transplant |
2.1% |
|
| Drug Ineffective |
12.9% |
| Epidural Lipomatosis |
10.3% |
| Weight Increased |
8.6% |
| Nocardiosis |
7.8% |
| Drug Hypersensitivity |
6.0% |
| Myelopathy |
5.2% |
| Pallor |
5.2% |
| Renal Failure Acute |
5.2% |
| Hypersensitivity |
4.3% |
| Loss Of Consciousness |
4.3% |
| Diabetes Insipidus |
3.4% |
| Product Substitution Issue |
3.4% |
| Pyrexia |
3.4% |
| Rash |
3.4% |
| Weight Decreased |
3.4% |
| Accidental Exposure |
2.6% |
| Adrenal Insufficiency |
2.6% |
| Adrenocortical Insufficiency Acute |
2.6% |
| Cushing's Syndrome |
2.6% |
| Hypertension |
2.6% |
|
| Secondary |
| Acute Lymphocytic Leukaemia |
33.4% |
| Product Used For Unknown Indication |
13.3% |
| Chromosome Analysis Abnormal |
10.0% |
| Drug Use For Unknown Indication |
5.6% |
| Burkitt's Lymphoma |
5.4% |
| B Precursor Type Acute Leukaemia |
4.8% |
| Asthma |
3.2% |
| Prophylaxis |
3.0% |
| Hypertension |
3.0% |
| Central Nervous System Lymphoma |
2.1% |
| Bacteraemia |
2.0% |
| Prostate Cancer Metastatic |
1.9% |
| Acute Myeloid Leukaemia |
1.8% |
| Rheumatoid Arthritis |
1.7% |
| Precursor T-lymphoblastic Lymphoma/leukaemia |
1.7% |
| Rhabdomyosarcoma |
1.6% |
| Antifungal Prophylaxis |
1.5% |
| Burkitt's Lymphoma Stage Iii |
1.5% |
| Pain |
1.4% |
| Crohn's Disease |
1.3% |
|
| Toxic Epidermal Necrolysis |
12.3% |
| Off Label Use |
11.7% |
| Vomiting |
8.9% |
| Weight Increased |
6.0% |
| Loss Of Consciousness |
5.7% |
| Thrombocytopenia |
5.5% |
| Pyrexia |
5.0% |
| Tachycardia Foetal |
4.2% |
| Pulmonary Embolism |
3.9% |
| Rhabdomyolysis |
3.7% |
| Sepsis |
3.7% |
| Spinal Fracture |
3.7% |
| Drug Ineffective |
3.4% |
| Multi-organ Failure |
3.4% |
| Rash |
3.4% |
| White Blood Cell Count Decreased |
3.4% |
| Zygomycosis |
3.4% |
| Pneumonitis |
3.1% |
| Renal Failure Acute |
2.9% |
| Tendonitis |
2.9% |
|
| Concomitant |
| Product Used For Unknown Indication |
30.2% |
| Drug Use For Unknown Indication |
17.0% |
| Premedication |
10.6% |
| Crohn's Disease |
6.7% |
| Pain |
4.5% |
| Prophylaxis |
4.0% |
| Hypertension |
3.5% |
| Hypopituitarism |
3.0% |
| Hiv Infection |
2.5% |
| Rheumatoid Arthritis |
2.3% |
| Depression |
1.9% |
| Growth Hormone Deficiency |
1.8% |
| Colitis Ulcerative |
1.7% |
| Nausea |
1.6% |
| Diabetes Mellitus |
1.5% |
| Osteoporosis |
1.5% |
| Asthma |
1.5% |
| Blood Corticotrophin Decreased |
1.4% |
| Acute Lymphocytic Leukaemia |
1.4% |
| Constipation |
1.4% |
|
| Vomiting |
17.6% |
| Weight Decreased |
6.8% |
| Death |
6.4% |
| Sepsis |
5.6% |
| Pneumonia |
5.5% |
| Pyrexia |
4.9% |
| Rash |
4.8% |
| Thrombocytopenia |
4.8% |
| Tachycardia |
4.6% |
| Infusion Related Reaction |
3.9% |
| Weight Increased |
3.8% |
| Renal Failure |
3.7% |
| Septic Shock |
3.7% |
| Urinary Tract Infection |
3.6% |
| Respiratory Failure |
3.6% |
| Urticaria |
3.5% |
| White Blood Cell Count Decreased |
3.5% |
| Nausea |
3.4% |
| Diarrhoea |
3.1% |
| Renal Failure Acute |
3.1% |
|
| Interacting |
| Cerebrovascular Accident |
14.5% |
| Hypertension |
14.5% |
| Addison's Disease |
8.1% |
| Asthma |
8.1% |
| Abortion Induced |
6.5% |
| Convulsion |
6.5% |
| Adrenal Insufficiency |
4.8% |
| Fibromyalgia |
4.8% |
| Hypopituitarism |
4.8% |
| Adrenalectomy |
3.2% |
| Analgesic Therapy |
3.2% |
| Antibiotic Therapy |
3.2% |
| Drug Use For Unknown Indication |
3.2% |
| Respiratory Failure |
3.2% |
| Upper Gastrointestinal Haemorrhage |
3.2% |
| Actinic Keratosis |
1.6% |
| Cardiac Failure |
1.6% |
| Gastrointestinal Haemorrhage |
1.6% |
| Glucocorticoids Decreased |
1.6% |
| High Density Lipoprotein Decreased |
1.6% |
|
| Toxicity To Various Agents |
17.4% |
| Drug Interaction |
8.7% |
| Hepatitis Toxic |
8.7% |
| Osteonecrosis Of Jaw |
8.7% |
| Respiratory Failure |
8.7% |
| Chills |
4.3% |
| Fall |
4.3% |
| Feeling Abnormal |
4.3% |
| Fibromyalgia |
4.3% |
| Loss Of Consciousness |
4.3% |
| Mixed Liver Injury |
4.3% |
| Osteonecrosis |
4.3% |
| Skin Burning Sensation |
4.3% |
| Vomiting |
4.3% |
| Weight Decreased |
4.3% |
| Weight Increased |
4.3% |
|
